USANA Health Sciences, Inc. (NYSE:USNA) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System cut its stake in USANA Health Sciences, Inc. (NYSE:USNA) by 2.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,486 shares of the company’s stock after selling 300 shares during the period. New York State Teachers Retirement System owned approximately 0.07% of USANA Health Sciences worth $723,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of USNA. Hsbc Holdings PLC purchased a new position in USANA Health Sciences in the third quarter valued at approximately $570,000. Pacer Advisors Inc. raised its holdings in USANA Health Sciences by 75.7% in the fourth quarter. Pacer Advisors Inc. now owns 337,371 shares of the company’s stock valued at $18,083,000 after buying an additional 145,373 shares during the period. Jacobs Levy Equity Management Inc. raised its holdings in USANA Health Sciences by 2.4% in the third quarter. Jacobs Levy Equity Management Inc. now owns 90,659 shares of the company’s stock valued at $5,314,000 after buying an additional 2,168 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in USANA Health Sciences by 3.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 213,887 shares of the company’s stock valued at $12,536,000 after buying an additional 8,084 shares during the period. Finally, Exchange Traded Concepts LLC raised its holdings in USANA Health Sciences by 7.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 16,534 shares of the company’s stock valued at $886,000 after buying an additional 1,162 shares during the period. 54.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently commented on the stock. StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Friday, January 12th. DA Davidson dropped their price objective on shares of USANA Health Sciences from $53.00 to $48.00 and set a “neutral” rating on the stock in a research note on Thursday, February 22nd.

USANA Health Sciences Stock Up 1.1 %

USNA opened at $43.47 on Friday. The firm has a market capitalization of $836.36 million, a P/E ratio of 13.17, a P/E/G ratio of 1.32 and a beta of 0.91. The firm’s 50 day moving average is $47.80 and its 200-day moving average is $49.37. USANA Health Sciences, Inc. has a 52-week low of $42.59 and a 52-week high of $69.60.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.52 by $0.35. The company had revenue of $221.08 million for the quarter, compared to analyst estimates of $206.70 million. USANA Health Sciences had a net margin of 6.93% and a return on equity of 13.49%. Equities analysts expect that USANA Health Sciences, Inc. will post 2.73 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider David Mulham Mulham sold 4,311 shares of USANA Health Sciences stock in a transaction on Thursday, February 29th. The shares were sold at an average price of $47.76, for a total value of $205,893.36. Following the completion of the sale, the insider now owns 7,825 shares in the company, valued at $373,722. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other USANA Health Sciences news, COO Walter Noot sold 5,240 shares of USANA Health Sciences stock in a transaction on Friday, March 8th. The shares were sold at an average price of $49.05, for a total value of $257,022.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider David Mulham Mulham sold 4,311 shares of USANA Health Sciences stock in a transaction on Thursday, February 29th. The stock was sold at an average price of $47.76, for a total transaction of $205,893.36. Following the completion of the transaction, the insider now directly owns 7,825 shares of the company’s stock, valued at approximately $373,722. The disclosure for this sale can be found here. Over the last quarter, insiders sold 24,807 shares of company stock worth $1,200,791. Insiders own 0.33% of the company’s stock.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.